Citadel Advisors
AMPE

Citadel Advisors’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Citadel Advisors’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-47
Closed -$7K – 14748
2022
Q1 		$7K Sell
47
-41
-47% -$5.99K ﹤0.01% 13411
2021
Q4 		$15K Sell
88
-34
-28% -$12.7K ﹤0.01% 13630
2021
Q3 		$61K Buy
122
+48
+65% +$22.3K ﹤0.01% 13259
2021
Q2 		$37K Sell
74
-82
-53% -$44K ﹤0.01% 13443
2021
Q1 		$79K Sell
156
-156
-50% -$80.5K ﹤0.01% 12643
2020
Q4 		$149K Buy
312
+151
+94% +$49.5K ﹤0.01% 9951
2020
Q3 		$46K Buy
161
+4
+3% +$991 ﹤0.01% 9637
2020
Q2 		$30K Buy
157
+37
+31% +$6.15K ﹤0.01% 9463
2020
Q1 		$15K Buy
120
+73
+155% +$13.2K ﹤0.01% 9365
2019
Q4 		$8K Sell
47
-1
-2% -$129 ﹤0.01% 9014
2019
Q3 		$7K Buy
+48
New +$6.4K ﹤0.01% 9060
2019
Q1 		– Sell
-108
Closed -$13K – 10092
2018
Q4 		$13K Sell
108
-1
-0.9% -$153 ﹤0.01% 8880
2018
Q3 		$17K Sell
109
-8
-7% -$3.34K ﹤0.01% 9043
2018
Q2 		$77K Sell
117
-22
-16% -$16.5K ﹤0.01% 8335
2018
Q1 		$141K Buy
139
+93
+202% +$77.9K ﹤0.01% 7573
2017
Q4 		$57K Buy
46
+13
+39% +$6.11K ﹤0.01% 7595
2017
Q3 		$6K Sell
33
-94
-74% -$14.9K ﹤0.01% 7454
2017
Q2 		$20K Buy
127
+49
+63% +$9.91K ﹤0.01% 7296
2017
Q1 		$19K Buy
+78
New +$21K ﹤0.01% 7263
2016
Q3 		– Sell
-70
Closed -$27K – 7950
2016
Q2 		$27K Buy
70
+20
+40% +$21.8K ﹤0.01% 6539
2016
Q1 		$34K Sell
50
-30
-38% -$20.2K ﹤0.01% 6349
2015
Q4 		$84K Sell
80
-64
-44% -$63.3K ﹤0.01% 6864
2015
Q3 		$125K Buy
144
+15
+12% +$12.5K ﹤0.01% 6725
2015
Q2 		$92K Sell
129
-140
-52% -$149K ﹤0.01% 7159
2015
Q1 		$608K Buy
269
+59
+28% +$101K ﹤0.01% 4627
2014
Q4 		$216K Sell
210
-180
-46% -$192K ﹤0.01% 5891
2014
Q3 		$413K Buy
390
+315
+420% +$530K ﹤0.01% 4870
2014
Q2 		$187K Sell
75
-11
-13% -$22.4K ﹤0.01% 5644
2014
Q1 		$164K Sell
86
-26
-23% -$61.5K ﹤0.01% 5723
2013
Q4 		$240K Buy
112
+35
+45% +$82.7K ﹤0.01% 4838
2013
Q3 		$173K Buy
+77
New +$149K ﹤0.01% 4900

Other funds holding AMPE

HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
BJL
Brighton Jones LLC Seattle, Washington $2.37B AUM 16.36% 1-Year Est. Return
WWM
Western Wealth Management Golden, Colorado $2.63B AUM 21.3% 1-Year Est. Return
IWM
IHT Wealth Management Chicago, Illinois $4.3B AUM 21.02% 1-Year Est. Return
CC
Courier Capital Buffalo, New York $2B AUM 24.36% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

Citadel Advisors's AMPE Position: Q2 2023 in Review

Citadel Advisors sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q2 2023, closing a stake of 382 shares — an estimated $1.78K sold.

Citadel Advisors first reported a position in AMPE in Q3 2013 and held it in 34 quarters. The position peaked at $824K in Q2 2014. 34 funds tracked by Wall St. Rank hold AMPE as of Q2 2023.

  • Citadel Advisors reported no remaining Ampio Pharmaceuticals Inc. position as of Q2 2023 after selling out during the quarter.
  • Citadel Advisors sold 382 Ampio Pharmaceuticals Inc. shares in Q2 2023, an estimated $1.78K.
  • Citadel Advisors first reported a position in Ampio Pharmaceuticals Inc. in Q3 2013 and held it in 34 quarters.
  • Citadel Advisors's Ampio Pharmaceuticals Inc. position peaked at $824K in Q2 2014.
  • 34 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q2 2023.

Based on Citadel Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.